Slideshows Images Quizzes

Emcyt

Last reviewed on RxList: 12/28/2016
Emcyt Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 6/1/2016

Emcyt (estramustine phosphate sodium) is an antineoplastic agent used to treat prostate cancer. Common side effects of Emcyt include:

The recommended daily dosage of Emcyt is 14 mg per kg of body weight taken in 3 to 4 divided doses at least 1 hour before or 2 hours after a meal. Tell your doctor if you have a history of stroke or heart attack, diabetes, heart disease, high blood pressure, migraine headaches, seizures, liver or kidney disease, or Paget's disease. Do not take Emcyt with any product that contains calcium such as milk. Emcyt may interact with antacids or vitamin and mineral supplements. Always use birth control while taking Emcyt as it may cause birth defects. This medication is not usually used in women and is unlikely to be used during pregnancy or breastfeeding.

Our Emcyt (estramustine phosphate sodium) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Emcyt Consumer Information

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using estramustine and call your doctor at once if you have a serious side effect such as:

  • chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
  • sudden numbness or weakness, especially on one side of the body;
  • sudden headache, confusion, problems with vision, speech, or balance;
  • chest pain, sudden cough, wheezing, rapid breathing, fast heart rate;
  • pain or swelling in one or both legs;
  • feeling short of breath, even with mild exertion;
  • swelling, rapid weight gain; or
  • easy bruising.

Less serious side effects may include:

  • nausea, loss of appetite, diarrhea, upset stomach;
  • feeling weak or tired;
  • breast swelling or tenderness; or
  • impotence.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Emcyt (Estramustine)

Emcyt Professional Information

SIDE EFFECTS

In a randomized, double-blind trial comparing therapy with EMCYT (estramustine) Capsules in 93 patients (11.5 to 15.9 mg/kg/day) or diethylstilbestrol (DES) in 93 patients (3.0 mg/day), the following adverse effects were reported:

  EMCYT
n=93
DES
n=93
CARDIOVASCULAR-RESPIRATORY
  Cardiac Arrest 0 2
  Cerebrovascular Accident 2 0
  Myocardial Infarction 3 1
  Thrombophlebitis 3 7
  Pulmonary Emboli 2 5
  Congestive Heart Failure 3 2
  Edema 19 17
  Dyspnea 11 3
  Leg Cramps 8 11
  Upper Respiratory Discharge 1 1
  Hoarseness 1 0
GASTROINTESTINAL
  Nausea 15 8
  Diarrhea 12 11
  Minor Gastrointestinal Upset 11 6
  Anorexia 4 3
  Flatulence 2 0
  Vomiting 1 1
  Gastrointestinal Bleeding 1 0
  Burning Throat 1 0
  Thirst 1 0
INTEGUMENTARY
  Rash 1 4
  Pruritus 2 2
  Dry Skin 2 0
  Pigment Changes 0 3
  Easy Bruising 3 0
  Flushing 1 0
  Night Sweats 0 1
  Fingertip-Peeling Skin 1 0
  Thinning Hair 1 1
BREAST CHANGES
  Tenderness 66 64
Enlargement    
  Mild 60 54
  Moderate 10 16
  Marked 0 5
MISCELLANEOUS
  Lethargy Alone 4 3
  Depression 0 2
  Emotional Lability 2 0
  Insomnia 3 0
  Headache 1 1
  Anxiety 1 0
  Chest Pain 1 1
  Hot Flashes 0 1
  Pain in Eyes 0 1
  Tearing of Eyes 1 1
  Tinnitus 0 1
LABORATORY ABNORMALITIES
Hematologic    
  Leukopenia 4 2
  Thrombopenia 1 2
Hepatic    
  Bilirubin Alone 1 5
  Bilirubin and LDH 0 1
  Bilirubin and SGOT 2 1
  Bilirubin, LDH and SGOT 2 0
  LDH and/or SGOT 31 28
Miscellaneous    
  Hypercalcemia-Transient 0 1

Read the entire FDA prescribing information for Emcyt (Estramustine)

Related Resources for Emcyt

Read the Emcyt User Reviews »

© Emcyt Patient Information is supplied by Cerner Multum, Inc. and Emcyt Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors